Michael J. Fox Foundation Backs Cannabis Research Bills
The Michael J. Fox Foundation (MJFF) calls on Congress to pass three cannabis bills that will pave the way for more scientific research into the benefits of cannabis on various health conditions.
MJFF is a nonprofit group dedicated to developing a cure and improved treatment for people living with Parkinson’s disease. It was founded by and named after the actor Michael J. Fox, who was diagnosed with Parkinson’s in 1991.
The first of the three pieces of legislation MJFF is supporting would improve the protection of cannabis research institutions, as well as increase the number of producers of research-grade cannabis. The second bill would enable the U.S. Department of Veterans Affairs (VA) to examine the effect of cannabis on chronic pain and PTSD, two of the most common medical conditions among veterans.
Finally, the third bill seeks to change the classification of marijuana from a Schedule I to a Schedule III drug under the Controlled Substances Act. This would also allow universities to carry out more studies into the medicinal properties of cannabis.
The foundation believes that current federal regulation is imposing barriers on unlocking the full therapeutic potential of cannabis. They add that it is also limiting researchers in providing sufficient evidence as to whether the plant has any beneficial effects on Parkinson’s symptoms and therapy.
Ted Thompson, the senior vice president of public policy for MJFF, said that the Foundation’s role is to work with Congress to allow access and funding for studies that will determine how medical cannabis can contribute to the lives and treatment of patients suffering from this disabling disease.
The UK is about to start clinical trials on the link between CBD and Parkinson’s disease with researchers hoping to prove that cannabidiol can alleviate the symptoms of psychosis known to accompany the illness.
The passing of these bills will open the doors to more research in the USA and hopefully the discovery of a possible cure or therapy for Parkinson’s disease.